Wire Stories
-
354AJC to Host the �Golden Bridge Short Video Campaign� Commemorating the 50th Year of ASEAN-Japan Friendship and Cooperation: A Grand Prize Winner will be Invited to Tokyo or One of the ASEAN Countries
Entry Period: Mar 10 � Jun 10, 2023 (JST) TOKYO–(BUSINESS WIRE)–The ASEAN-Japan Centre (AJC) has launched the “Golden Bridge Short Video Campaign”...
-
436Netcracker Highlights Ongoing Commitment to Region at DTW Asia 2023
Netcracker to Discuss Telco to Techco Transformation and New Approaches to Maximize Growth and Revenue at Bangkok Event WALTHAM, Mass.–(BUSINESS WIRE)–Netcracker Technology...
-
579Zuora Expands India Footprint with New Office in Chennai
With a 200-person capacity, engineering talent at the new office will help drive global product innovation in the Subscription Economy Zuora�s team...
-
583Zuora Expands India Footprint with New Office in Chennai
With a 200-person capacity, engineering talent at the new office will help drive global product innovation in the Subscription Economy Zuora�s team...
-
402
Zuora Expands India Footprint with New Office in Chennai
With a 200-person capacity, engineering talent at the new office will help drive global product innovation in the Subscription Economy Zuora�s team...
-
472Khan World School at ASU Prep Accelerates Expansion Thanks to Exceptional Academic Performance by Pilot Cohort
Online Honors Program Enrolling Students in Grades 6-12 for 2023-24 School Year TEMPE, Ariz.–(BUSINESS WIRE)–Building on its successful pilot of a unique...
-
425Khan World School at ASU Prep Accelerates Expansion Thanks to Exceptional Academic Performance by Pilot Cohort
Online Honors Program Enrolling Students in Grades 6-12 for 2023-24 School Year TEMPE, Ariz.–(BUSINESS WIRE)–Building on its successful pilot of a unique...
-
435Khan World School at ASU Prep Accelerates Expansion Thanks to Exceptional Academic Performance by Pilot Cohort
Online Honors Program Enrolling Students in Grades 6-12 for 2023-24 School Year TEMPE, Ariz.–(BUSINESS WIRE)–Building on its successful pilot of a unique...
-
420InnoCare Announces First Subject Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in China
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today...
-
492Astellas and Seagen Announce China�s National Medical Products Administration Accepts Biologics License Application for Enfortumab Vedotin in Certain Patients with Locally Advanced or Metastatic Urothelial Cancer
� Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced...
